BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33219340)

  • 21. Collaboration between hematopoietic stem cell donor registry and cord blood banks.
    Raffoux C
    Transplant Proc; 2010 Oct; 42(8):3258-9. PubMed ID: 20970667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood and bone marrow donor registry of Istanbul medical faculty activity and experience in past 3 years : A cross-sectional documentation of TRIS activity: the first blood and marrow registry in Turkey.
    Savran Oguz F; Erol A; Kekik Cinar C; Kivanc D; Suleymanoglu M; Ogret Y; Senturk Ciftci H; Kalayoglu Besisik S
    Cell Tissue Bank; 2022 Sep; 23(3):483-488. PubMed ID: 34655355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.
    Szer J; Weisdorf D; Querol S; Foeken L; Madrigal A
    Bone Marrow Transplant; 2020 Oct; 55(10):2043-2044. PubMed ID: 32203269
    [No Abstract]   [Full Text] [Related]  

  • 25. High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: how can they be used to improve unrelated donor searches?
    Pingel J; Solloch UV; Hofmann JA; Lange V; Ehninger G; Schmidt AH
    Hum Immunol; 2013 Mar; 74(3):330-40. PubMed ID: 23200758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association.
    Boo M; van Walraven SM; Chapman J; Lindberg B; Schmidt AH; Shaw BE; Switzer GE; Yang E; Egeland T;
    Blood; 2011 Jan; 117(1):21-5. PubMed ID: 20921337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New global reporting system for serious (product) events and adverse reactions in hematopoietic stem cell donation and transplantation.
    Jöris M; Pustjens E; Mengling T; Fechter M; Wiersum-Osselton J; Bokhorst A; Foeken L
    Cell Tissue Bank; 2021 Jun; 22(2):191-197. PubMed ID: 32902671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit of donor centre: guidelines by the World Marrow Donor Association Quality and Regulation Working Group.
    Weber M; Sacchi N; Haun S; Tistl I; Thompson S; Sengomona H; Ahmed SM; Kürsteiner O; Schwarz C; Wuchter J
    Bone Marrow Transplant; 2022 Mar; 57(3):466-472. PubMed ID: 35031710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
    Tiercy JM; Stadelmann S; Chapuis B; Gratwohl A; Schanz U; Seger RA; Faveri GN; Kern M; Morell A; Schwabe R; Schneider P
    Bone Marrow Transplant; 2003 Sep; 32(6):623-7. PubMed ID: 12953136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.
    Hurley CK; Raffoux C;
    Bone Marrow Transplant; 2004 Jul; 34(2):103-10. PubMed ID: 15170173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience.
    Balassa K; Griffiths A; Winstone D; Li Y; Rocha V; Pawson R
    Transfus Med; 2019 Oct; 29(5):332-337. PubMed ID: 31209947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
    Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor Association.
    Jöris MM; Schmidt AH; Bernas SN; Feinberg J; Sacchi N; Elmoazzen H; Fournier D; Oguz F; Oliveira D; Yang KL; Mousavi SA; Moomivand S; Abecasis M; Villa J; Fechter MM; Seval GC; Jeyarajah T; Devine SM; Shaw BE; Galarza P; Malan R; Harvey C; Forman SJ; Foeken L
    Bone Marrow Transplant; 2022 Jun; 57(6):1021-1024. PubMed ID: 35397653
    [No Abstract]   [Full Text] [Related]  

  • 35. [Discrepancies between human leukocyte antigen registry typing and confirmatory typing results of unrelated hematopoietic stem cell donors].
    Ko DH; Chung HY; Lim YM; Han BY; Song EY; Park MH
    Korean J Lab Med; 2010 Dec; 30(6):668-74. PubMed ID: 21157155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
    Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study.
    Thibodeaux SR; Coble D; Day V; Fontaine MJ; Gabelli M; Gardiner N; Geach T; Schwartz J; Vasovic LV; Wyre R; Girdlestone J;
    Transfusion; 2023 Apr; 63(4):782-790. PubMed ID: 36924403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to managing volunteer marrow donor registry HLA data. Algorithms for directing donor center-initiated HLA-DR typing of selected donors.
    Schuler U; Rutt C; Baier D; Keller JV; Stahr A; Grathwohl A; Ehninger G
    Rev Immunogenet; 2000; 2(4):541-6. PubMed ID: 12361095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
    Hurley CK; Wade JA; Oudshoorn M; Middleton D; Kukuruga D; Navarrete C; Christiansen F; Hegland J; Ren EC; Andersen I; Cleaver SA; Brautbar C; Raffoux C
    Hum Immunol; 1999 Apr; 60(4):347-60. PubMed ID: 10363727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.